Objective: The objective of this study was to assess the clinical impact and outcome of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection on children with cancer or who received a hematopoietic stem cell transplantation (HSCT). Study design: The Italian Association of Pediatric Hematology and Oncology (AIEOP) performed a nationwide, multicenter, observational cohort study, including consecutive patients between April 2020 to November 2022. Results: Twenty-five Italian centers participated and 455 patients were enrolled. We reported a significative increasing trend of symptomatic cases over the years, while the number of non-mild infections remained stable. An early infection after the oncological diagnosis (<60 days) and severe neutropenia have been identified as independent risk factors for developing moderate, severe or critical infections. The percentage of asymptomatic and mildly symptomatic patients who stopped chemotherapy reduced over the years of the pandemic. Nine patients died, but no death was attributed to SARS-CoV-2 infection. Conclusions: SARS-CoV-2 infection presented a self-limiting, benign course in the Italian pediatric onco-hematology population during the pandemic and its main consequence has been the discontinuation of cancer-directed therapies. The rate of asymptomatic patients who stopped chemotherapy reduced over the years, suggesting that the continuation of chemotherapy is a feasible option.

SARS-CoV-2 Infection in the Pediatric Oncology Population: The Definitive Comprehensive Report of the Infectious Diseases Working Group of AIEOP / Zama, Daniele; Zanaroli, Andrea; Corbelli, Agnese; LO VECCHIO, Andrea; DEL BENE, Margherita; Colombini, Antonella; Compagno, Francesca; Barone, Angelica; Fontanili, Ilaria; Rosaria D’Amico, Maria; Rosaria Papa, Maria; Grazia Petris, Maria; Calore, Elisabetta; Montalto, Shana; Meneghello, Linda; Brescia, Letizia; Mura, Rosamaria; La Spina, Milena; Muggeo, Paola; Rinieri, Simona; Meazza, Cristina; Perruccio, Katia; Cellini, Monica; Spadea, Manuela; Mercolini, Federico; Petroni, Valeria; De Santis, Raffaella; Soncini, Elena; Provenzi, Massimo; Giurici, Nagua; Ziino, Ottavio; Tridello, Gloria; Cesaro, Simone. - In: THE JOURNAL OF INFECTIOUS DISEASES. - ISSN 0022-1899. - (2023), pp. 1-9. [10.1093/infdis/jiad496]

SARS-CoV-2 Infection in the Pediatric Oncology Population: The Definitive Comprehensive Report of the Infectious Diseases Working Group of AIEOP

Andrea Lo Vecchio;Margherita Del Bene;
2023

Abstract

Objective: The objective of this study was to assess the clinical impact and outcome of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection on children with cancer or who received a hematopoietic stem cell transplantation (HSCT). Study design: The Italian Association of Pediatric Hematology and Oncology (AIEOP) performed a nationwide, multicenter, observational cohort study, including consecutive patients between April 2020 to November 2022. Results: Twenty-five Italian centers participated and 455 patients were enrolled. We reported a significative increasing trend of symptomatic cases over the years, while the number of non-mild infections remained stable. An early infection after the oncological diagnosis (<60 days) and severe neutropenia have been identified as independent risk factors for developing moderate, severe or critical infections. The percentage of asymptomatic and mildly symptomatic patients who stopped chemotherapy reduced over the years of the pandemic. Nine patients died, but no death was attributed to SARS-CoV-2 infection. Conclusions: SARS-CoV-2 infection presented a self-limiting, benign course in the Italian pediatric onco-hematology population during the pandemic and its main consequence has been the discontinuation of cancer-directed therapies. The rate of asymptomatic patients who stopped chemotherapy reduced over the years, suggesting that the continuation of chemotherapy is a feasible option.
2023
SARS-CoV-2 Infection in the Pediatric Oncology Population: The Definitive Comprehensive Report of the Infectious Diseases Working Group of AIEOP / Zama, Daniele; Zanaroli, Andrea; Corbelli, Agnese; LO VECCHIO, Andrea; DEL BENE, Margherita; Colombini, Antonella; Compagno, Francesca; Barone, Angelica; Fontanili, Ilaria; Rosaria D’Amico, Maria; Rosaria Papa, Maria; Grazia Petris, Maria; Calore, Elisabetta; Montalto, Shana; Meneghello, Linda; Brescia, Letizia; Mura, Rosamaria; La Spina, Milena; Muggeo, Paola; Rinieri, Simona; Meazza, Cristina; Perruccio, Katia; Cellini, Monica; Spadea, Manuela; Mercolini, Federico; Petroni, Valeria; De Santis, Raffaella; Soncini, Elena; Provenzi, Massimo; Giurici, Nagua; Ziino, Ottavio; Tridello, Gloria; Cesaro, Simone. - In: THE JOURNAL OF INFECTIOUS DISEASES. - ISSN 0022-1899. - (2023), pp. 1-9. [10.1093/infdis/jiad496]
File in questo prodotto:
File Dimensione Formato  
Zama - (Covid) - JID 2023.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Dominio pubblico
Dimensione 573.65 kB
Formato Adobe PDF
573.65 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/956014
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 1
social impact